Merck Acquires Terns Pharmaceuticals for $6.7B Merck buys Terns Pharmaceuticals for $6.7B, gaining leukemia drug TERN-701 to offset Keytruda's 2028 patent cliff. Learn what this means for CML treatment.

Merck Acquires Terns Pharmaceuticals for $6.7B
Merck buys Terns Pharmaceuticals for $6.7B, gaining leukemia drug TERN-701 to offset Keytruda's 2028 patent cliff. Learn what this means for CML t...

#MerckTerns #TERN701 #CML #MRK #BiotechMergers
https://scrollworthy.org/trending/terns-pharmaceuticals